The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions

Episode 72 of The Buyout Show explores the growing wave of private equity investment in legal cannabis dispensaries across the United States. With federal rescheduling on the horizon in mid-2026, firms like Curaleaf and Green Thumb Industries are consolidating smaller operators at a rapid clip. Lucas and Luna break down the economics: how the average dispensary acquisition multiple has climbed from 6x to 9x EBITDA in two years, the role of state-level licensing bottlenecks, and why PE firms see cannabis as an infrastructure play rather than a growth bet. They also examine the risks — from regulatory whiplash to 280E tax burdens — and debate whether this roll-up mirrors the urgent-care consolidation wave or something entirely new. A concrete case: the recent acquisition of a 12-store chain in Michigan for $85 million by a New York-based PE firm. Specific, data-driven, and grounded in the week's news.

#PrivateEquity #Cannabis #Dispensaries #RollUp #Marijuana #Curaleaf #GreenThumbIndustries #Michigan #Acquisition #Business #Finance #Investment #Regulation #280E #Consolidation #FexingoBusiness #BusinessPodcast #TheBuyoutShow

Keep every episode free: buymeacoffee.com/fexingo

Private equity has rolled up everything from dental clinics to parking lots. But the security guard industry—fragmented, low-margin, labor-intensive—was long seen as untouchable. This episode examines how firms like Sentinel Capital Partners and Alpine Investors are now consolidating contract security, buying mom-and-pop guard companies and rolling them into regional giants. Lucas and Luna break down the economics: 5 percent margins, 300 percent annual turnover, and the financial engineering that makes it work. They also discuss the risks—including what happens to wages and working conditions when private equity squeezes the spread between what the client pays and what the guard takes home. Plus: a look at how technology is reshaping the guard business, from AI surveillance to automated patrol. A rare inside look at a boring industry that touches every office building, hospital, and warehouse in America.

#PrivateEquity #SecurityGuard #BusinessPodcast #FexingoBusiness #RollUp #PE #SentinelCapital #AlpineInvestors #Consolidation #LowMargin #LaborIntensive #ContractSecurity #FragmentedIndustry #Buyout #Business #Finance #Economics #MergersAndAcquisitions

Keep every episode free: buymeacoffee.com/fexingo

This episode of The Buyout Show dives into the quiet but rapid consolidation of franchised tire and auto-service chains. Lucas and Luna examine why private equity is paying 8–10 times EBITDA for regional tire shop networks, the economics of the roll-up playbook, and a specific case: the 2023 acquisition of Tire-Rama by a New York-based sponsor. They break down the math behind the consolidation thesis—predictable cash flows, sticky B2B demand, and the push into commercial fleet servicing. Plus, a look at the growing regulatory scrutiny around M&A in auto repair and what it means for independent shop owners. If you want to understand how your local tire store might soon be owned by a private equity firm, this episode covers the blueprint.

#PrivateEquity #TireShops #RollUp #AutoService #Franchise #MergersAndAcquisitions #BusinessPodcast #Business #Finance #FexingoBusiness #PEPlaybook #TireRama #FleetServicing #EBITDA #Consolidation #IndependentBusinesses #DealSourcing #FranchisedDealers

Keep every episode free: buymeacoffee.com/fexingo

Episode 69 of The Buyout Show with Fexingo. Lucas and Luna examine the wave of private equity acquisitions of independent pharmacies, focusing on the specific strategy of roll-ups like the one led by Oak Street Health's former executives. They discuss the economics: how a single independent pharmacy generates roughly $3-5 million in revenue but only 8-12% EBITDA margins, and how consolidation into a 50-plus location entity can boost margins to 20% through centralized purchasing and back-office efficiencies. They also touch on the regulatory risks, including the FTC's recent scrutiny of pharmacy benefit manager practices. Hosts: Lucas and Luna.

#PrivateEquity #Pharmacies #RollUps #IndependentPharmacy #OakStreetHealth #EBITDA #FTC #PBMs #PharmacyBenefitManagers #Consolidation #Healthcare #MergersAndAcquisitions #LBO #BusinessStrategy #FexingoBusiness #BusinessPodcast #TheBuyoutShow #RetailPharmacy

Keep every episode free: buymeacoffee.com/fexingo

Lucas and Luna examine the wave of private equity acquisitions of small animal veterinary practices, focusing on consolidation metrics from 2021-2026. They discuss the roll-up of general practice clinics, how aggregators like PetVet Care Centers and VCA operate, the impact on vet salaries and patient pricing, and the tension between clinical autonomy and corporate efficiency. The episode uses the acquisition of a 10-doctor practice in Charlotte, North Carolina as a concrete case, walking through valuation multiples, earn-out structures, and the role of debt financing in these deals.

#PrivateEquity #VeterinaryClinics #PetCare #RollUps #PetVetCareCenters #VCA #DealRoom #BusinessAcquisitions #ValuationMultiples #LBO #VeterinaryMedicine #PetIndustry #Consolidation #HealthcarePE #FexingoBusiness #BusinessPodcast #TheBuyoutShow #Business

Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Buyout Show, Lucas and Luna examine the quiet roll-up of the hearing aid industry by private equity. With an aging population and margin-rich business models, firms like Sonova and Demant have seen their clinic networks snapped up. The hosts break down why audiology practices are a PE dream: sticky patient relationships, high margin recurring revenue from batteries and fittings, and a fragmented market ripe for consolidation. They look at the economics of a typical practice, the regulatory changes from the 2017 OTC Hearing Aid Act that shifted the landscape, and whether this consolidation will ultimately help or hurt patients. A case study in how demographics and dealmaking intersect.

#PrivateEquity #HearingAid #Audiology #RollUp #HealthcareM&A #Demographics #Sonova #Demant #OtcHearingAid #FragmentedMarket #Consolidation #Business #Finance #Investing #Healthcare #FexingoBusiness #BusinessPodcast #BuyoutShow

Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Buyout Show with Fexingo, Lucas and Luna dive into one of the hottest and most controversial roll-up plays in healthcare: dental support organizations, or DSOs. Private equity firms have backed over 400 DSOs in the last decade, aggregating thousands of independent dental practices under management. Lucas breaks down the economics — how DSOs claim to save dentists 30% on overhead through centralized billing, procurement, and HR — but also raises the hard question: does consolidation actually improve patient outcomes? They look at the case of Heartland Dental, the largest DSO with over 1,700 offices, and the recent failed IPO of SmileDirectClub as cautionary tales. Luna pushes back on the narrative that PE is purely extractive, pointing to data showing DSO-affiliated dentists report higher job satisfaction. The episode lands on a nuanced take: DSO roll-ups create real efficiencies, but the long-term risk is that profit pressure leads to assembly-line dentistry, favoring volume over care. Recorded June 21, 2026.

#PrivateEquity #DentalSupportOrganizations #DSO #RollUp #HealthcareConsolidation #HeartlandDental #SmileDirectClub #Business #Acquisitions #Dentistry #PE #RollUpStrategy #FexingoBusiness #BusinessPodcast #TheBuyoutShow #Lucas #Luna #PracticeManagement

Keep every episode free: buymeacoffee.com/fexingo

Episode 65 of The Buyout Show dives into the quiet roll-up of franchised auto dealerships by private equity firms. Lucas and Luna examine the specific case of AutoNation's recent acquisition spree, the economics of buying a Toyota or Honda franchise for $50 million-plus, and why PE sees dealerships as a recession-resistant cash machine. They also discuss how the shift to electric vehicles is changing dealership valuations and why manufacturers like Ford are pushing back on consolidation. Plus: a candid moment about listener support keeping the show ad-free.

#PrivateEquity #AutoDealerships #FranchiseRollUp #AutoNation #CarDealershipInvesting #PEBuyouts #ElectricVehicles #Ford #Toyota #Honda #DealershipValuations #BusinessAcquisitions #RollUpStrategy #CashFlowInvesting #FexingoBusiness #BusinessPodcast #TheBuyoutShow #LucasAndLuna

Keep every episode free: buymeacoffee.com/fexingo

Private equity has quietly consolidated a surprising industry: cremation services. Lucas and Luna explore how firms like Service Corporation International and smaller PE-backed players have rolled up funeral homes and crematories, driven by demographic shifts and margin logic. With cremation rates in the U.S. crossing 60% in 2025, the economics are shifting — and PE is paying attention. They break down the numbers: a typical cremation generates $1,500–$3,000 in revenue versus $7,000–$10,000 for a traditional burial, but the operating margins are wider and the capital requirements lower. The hosts discuss the consolidation playbook, the regulatory hurdles, and why this roll-up wave hasn't hit the headlines like dental or vet practices. A specific look at how death care became a slow-burn PE target.

#PrivateEquity #CremationServices #DeathCare #FuneralHomes #ServiceCorporationInternational #RollUp #Consolidation #Demographics #Investing #BusinessStrategy #Finance #BusinessPodcast #FexingoBusiness #PEPlaybook #CremationRates #DeathIndustry #MergersAndAcquisitions #EconomicTrends

Keep every episode free: buymeacoffee.com/fexingo

Episode 63 of The Buyout Show examines the rapid consolidation of veterinary diagnostic laboratories by private equity. Lucas and Luna break down the economics: full-service labs like IDEXX and Antech dominate, but PE-backed platforms like Ethos Diagnostics and VCA's recent lab acquisitions are targeting regional and reference labs. They discuss why diagnostics are a sticky, high-margin business — consistent recurring revenue from sample testing, low customer churn, and integration with practice management software. The hosts walk through a typical roll-up strategy: acquire a regional lab, centralize processing, cut overhead, and expand the test menu. They also touch on regulatory risks, including the FTC's scrutiny of lab consolidation, and the impact on independent veterinarians who may face higher prices or longer turnaround times. Specific numbers: the U.S. veterinary diagnostics market is valued at $4.2 billion in 2026, growing at 8% CAGR, with PE-backed platforms now controlling roughly 25% of reference lab volume.

#VeterinaryDiagnostics #PrivateEquity #RollUps #LabConsolidation #IDEXX #Antech #EthosDiagnostics #VCA #BusinessAcquisition #HealthcarePE #PetCare #Veterinary #DiagnosticTesting #FTC #MarketConsolidation #BusinessPodcast #FexingoBusiness #TheBuyoutShow

Keep every episode free: buymeacoffee.com/fexingo